Results 51 to 60 of about 27,953 (293)

Perception-aware time optimal path parameterization for quadrotors

open access: yes, 2020
The increasing popularity of quadrotors has given rise to a class of predominantly vision-driven vehicles. This paper addresses the problem of perception-aware time optimal path parametrization for quadrotors.
Karaman, Sertac   +2 more
core   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

open access: yesMolecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak   +4 more
wiley   +1 more source

Differential flatness and absolute equivalence [PDF]

open access: yes, 1994
In this paper we give a formulation of differential flatness-a concept originally introduced by Fliess, Levine, Martin, and Rouchon (1992)-in terms of absolute equivalence between exterior differential systems.
Murray, R. M.   +2 more
core  

A 1.2 V and 69 mW 60 GHz Multi-channel Tunable CMOS Receiver Design [PDF]

open access: yes, 2015
A multi-channel receiver operating between 56 GHz and 70 GHz for coverage of different 60 GHz bands worldwide is implemented with a 90 nm Complementary Metal-Oxide Semiconductor (CMOS) process.
Oncu, A.
core   +2 more sources

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

Differential Flatness Based-Control Strategy of a Two-Port Bidirectional Supercapacitor Converter for Hydrogen Mobility Applications

open access: yesEnergies, 2020
This article is focused on an original control approach applied to a transportation system that includes a polymer electrolyte membrane fuel cell (PEMFC) as the main energy source and supercapacitors (SC) as the energy storage backup. To interface the SC
Phatiphat Thounthong   +7 more
doaj   +1 more source

Differential Flatness and Absolute Equivalence [PDF]

open access: yes, 1995
In this paper we give a formulation of differential flatness---a concept originally introduced by Fleiss, Levine, Martin, and Rouchon---in terms of absolute equivalence between exterior differential systems.
Murray, Richard M.   +2 more
core   +1 more source

Flatness optimization of micro-injection moulded parts: The case of a PMMA microfluidic component [PDF]

open access: yes, 2011
Micro-injection moulding (µ-IM) has attracted a lot of interest because of its potential for the production of low-cost, miniaturized parts in high-volume.
Alcock, Jeffrey R.   +5 more
core   +1 more source

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

open access: yesMolecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung   +17 more
wiley   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

open access: yesMolecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy